ARCA Discovery, Inc. closed an $18M Series B led by Skyline Ventures and additional new investor InterWest Partners, previous investors Atlas Ventures, Boulder Ventures and the Peierls Foundation also participated in the round. ARCA is aiming for an NDA submission in 2007 for Bucindolol, a next-generation beta-blocker and vasodilator for heart failure, and plans to [...]

• 185http://clsdf.com/2007/06/arca-discovery-18m-series-b/ARCA+Discovery%3A+%2418M+Series+B2007-06-13+23%3A15%3A00admin

I’m always excited when my new edition of Genetic Engineering & Biotechnology News shows up. This is the periodical that keeps me at least efforting to maintain an awareness of the leading edge of discovery, translational medicine, bioprocessing and biobusiness. If you do not receive it yet sign up for your free subscription (here). How [...]

• 184http://clsdf.com/2007/06/i%e2%80%99m-always-excited-when%e2%80%a6/I%E2%80%99m+Always+Excited+When%E2%80%A62007-06-13+23%3A11%3A00admin

Congratulations to ValveXchange for taking top honors in the bioscience category and third place overall in the Bard Center for Entrepreneurship at the University Colorado, Denver and Health Sciences Center 6th Annual Business Plan Competition. Way to go Dr. Vesely! ValveXchange is a medical device company developing a bioprosthetic heart valve with a percutaneously-exchangeable leaflet [...]

• 183http://clsdf.com/2007/06/valvexchange-bard-bioscience-winner/ValveXchange%3A+Bard+Bioscience+Winner%212007-06-13+23%3A04%3A00admin